Clinical Trial Update: RESULT: Reliable, Emergent Solution Using Liprotamase Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial update on Liprotamase for exocrine pancreatic insufficiency, including use in cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency

Drugs mentioned

• Liprotamase (liprotamase)

Snippet

Sponsor: Anthera Pharmaceuticals | Conditions: Exocrine Pancreatic Insufficiency, Cystic Fibrosis | Phase 3 | Status: UNKNOWN